MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 196 filers reported holding MEDICINES CO in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,804,000 | +66.5% | 115,423 | -2.0% | 0.02% | +54.5% |
| Q3 2019 | $5,888,000 | +49.0% | 117,754 | +8.7% | 0.01% | +37.5% |
| Q2 2019 | $3,952,000 | +34.1% | 108,355 | +2.8% | 0.01% | +33.3% |
| Q1 2019 | $2,946,000 | +42.9% | 105,403 | -2.2% | 0.01% | +20.0% |
| Q4 2018 | $2,062,000 | -34.5% | 107,746 | +2.3% | 0.01% | -16.7% |
| Q3 2018 | $3,150,000 | -18.5% | 105,317 | -0.0% | 0.01% | -25.0% |
| Q2 2018 | $3,866,000 | +10.6% | 105,354 | -0.8% | 0.01% | +14.3% |
| Q1 2018 | $3,497,000 | +17.6% | 106,173 | -2.4% | 0.01% | +16.7% |
| Q4 2017 | $2,974,000 | -27.3% | 108,795 | -1.5% | 0.01% | -33.3% |
| Q3 2017 | $4,092,000 | -11.9% | 110,468 | -9.6% | 0.01% | -10.0% |
| Q2 2017 | $4,646,000 | -28.5% | 122,238 | -8.0% | 0.01% | -23.1% |
| Q1 2017 | $6,494,000 | +37.8% | 132,806 | -4.3% | 0.01% | +30.0% |
| Q4 2016 | $4,711,000 | -12.5% | 138,806 | -2.7% | 0.01% | -9.1% |
| Q3 2016 | $5,386,000 | +13.3% | 142,706 | +0.9% | 0.01% | +10.0% |
| Q2 2016 | $4,755,000 | +6.4% | 141,406 | +0.5% | 0.01% | 0.0% |
| Q1 2016 | $4,471,000 | -2.4% | 140,732 | +14.7% | 0.01% | -9.1% |
| Q4 2015 | $4,581,000 | -0.2% | 122,695 | +1.5% | 0.01% | -8.3% |
| Q3 2015 | $4,588,000 | +32.6% | 120,860 | -0.1% | 0.01% | +50.0% |
| Q2 2015 | $3,461,000 | +3.8% | 120,960 | +1.7% | 0.01% | 0.0% |
| Q1 2015 | $3,333,000 | -0.6% | 118,959 | -1.8% | 0.01% | 0.0% |
| Q4 2014 | $3,352,000 | +25.1% | 121,159 | +0.9% | 0.01% | +14.3% |
| Q3 2014 | $2,679,000 | -22.3% | 120,046 | +1.2% | 0.01% | -22.2% |
| Q2 2014 | $3,448,000 | +5.5% | 118,665 | +3.2% | 0.01% | 0.0% |
| Q1 2014 | $3,267,000 | -26.2% | 114,965 | +0.3% | 0.01% | -25.0% |
| Q4 2013 | $4,425,000 | +16.1% | 114,565 | +0.8% | 0.01% | +9.1% |
| Q3 2013 | $3,810,000 | +27.0% | 113,665 | +16.5% | 0.01% | +10.0% |
| Q2 2013 | $3,001,000 | -6.3% | 97,574 | +1.8% | 0.01% | -9.1% |
| Q1 2013 | $3,203,000 | – | 95,830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |